Royalty Pharma plc (RPRX)

Earnings & Profitability History

Latest EPS

$0.64

Net Income

214.2M

Financial Fundamentals

RPRX • Quarterly Data • 5Y View

Date	Net Income ($B)	NI YoY %	TTM NI	EPS	EPS YoY %	TTM EPS
2025-12-31	0.21	+2.9%	0.77	0.64	+36.2%	1.95
2025-09-30	0.29	-47.0%	0.76	0.67	-45.1%	1.78
2025-06-30	0.03	-70.4%	1.02	0.09	-59.1%	2.33
2025-03-31	0.24	+4888.5%	1.09	0.55	+5400.0%	2.47
2024-12-31	0.21	-57.9%	0.86	0.47	-68.2%	1.93
2024-09-30	0.54	+654.3%	1.15	1.22	+481.0%	2.94
2024-06-30	0.10	-55.2%	0.67	0.23	-54.9%	1.93
2024-03-31	0.00	-98.6%	0.80	0.01	-98.7%	2.21
2023-12-31	0.49	+208.4%	1.13	1.48	+200.7%	2.96
2023-09-30	0.07	-49.4%	0.18	0.21	-53.3%	0.01
2023-06-30	0.23	-25.2%	0.25	0.51	-47.4%	0.25
2023-03-31	0.34	+558.3%	0.33	0.76	+533.3%	0.71
2022-12-31	-0.46	-5870.3%	0.04	-1.47	-7919.1%	0.07
2022-09-30	0.14	+40.0%	0.51	0.45	+32.4%	1.56
2022-06-30	0.30	-30.9%	0.47	0.97	-39.4%	1.45
2022-03-31	0.05	-25.1%	0.60	0.12	-57.1%	2.08
2021-12-31	0.01	-95.4%	0.62	0.02	+102.4%	2.24
2021-09-30	0.10	-64.9%	0.78	0.34	-57.0%	1.42
2021-06-30	0.44	-0.3%	0.97	1.60	+1677.8%	1.87
2021-03-31	0.07	-3.0%	0.97	0.28	+40.0%	0.36
2020-12-31	0.17	-88.0%	0.98	-0.80	-208.1%	0.28
2020-09-30	0.29	-28.9%	2.22	0.79	-31.3%	1.82
2020-06-30	0.44	+191.4%	2.34	0.09	-79.1%	2.18
2020-03-31	0.07	-80.6%	2.05	0.20	-80.8%	2.52
2019-12-31	1.42	—	2.35	0.74	—	3.36
2019-09-30	0.41	—	—	1.15	—	—
2019-06-30	0.15	—	—	0.43	—	—
2019-03-31	0.37	—	—	1.04	—	—

Year	Net Income ($B)	Growth %	EPS	EPS Growth %
2025	0.77	-10.2%	2.33	+20.7%
2024	0.86	-24.3%	1.93	-43.4%
2023	1.13	+2549.5%	3.41	+3310.0%
2022	0.04	-93.1%	0.10	-93.3%
2021	0.62	-36.4%	1.49	+16.4%
2020	0.98	-58.5%	1.28	-80.7%
2019	2.35	+70.5%	6.63	+70.4%
2018	1.38	+13.9%	3.89	+13.7%
2017	1.21	+113.8%	3.42	+267.7%
2016	0.57	-2.7%	0.93	-3.1%
2015	0.58	—	0.96	—